Nobel Biocare Acquires Steri-Oss Inc. -- America's Leading Dental Implant Company
"By joining forces with Steri-Oss, we have secured a major position in the global dental market that will allow us to take advantage of the significant growth potential of dental implants," comments Jack Forsgren, President and CEO of Nobel Biocare AB. "Steri-Oss has had strong growth and good profitability in recent years due to the steady launch of new, innovative products and fits our strategic needs perfectly. The combined company will have a broader product range, a considerably larger sales force, an improved cost structure, as well as expanded research and development resources."
According to company officials, the acquisition will result in the most comprehensive line of dental implants offered on the market today. The combined resources will cover all segments of dental implants, with established channels for launching and marketing complementary products and technologies.
"The combined strength of Steri-Oss and Nobel Biocare will create important opportunities for both the dental profession and the development of new dental implant technologies," said Ken Darienzo, chairman of Steri-Oss. "Dental professionals can now look to one manufacturer for virtually every option in implant treatment."
The combination of Nobel Biocare's and Steri-Oss's extensive interface with general dentists also provides a platform for continued rapid growth for Procera(R). Nobel Biocare also announced that it plans to increase consumer awareness of dental implants by launching a major marketing program.
"One of the goals of this acquisition is to enhance the visibility and raise the acceptance of oral rehabilitation with dental implants to the level of other dental restorative techniques," said Nobel Biocare's Forsgren.
The acquisition is subject to shareholder and regulatory approval. Completion is expected sometime in the fall of 1998.
Nobel Biocare is an international dental technology company and is a world leader in dental implants with subsidiaries in more than 20 countries. Based in Gothenburg, Sweden, the company was established in 1981 and is one of Sweden's leading health care engineering companies.
Nobel Biocare pioneered the development of the dental implant market with Branemark System(R), which today holds a leading position in the global market. It also markets Procera(R), a high tech process for the laboratory production of dental bridges and crowns using CAD/CAM technology.
Following the acquisition, Nobel Biocare will market three brand names within dentistry, Branemark System(R) and Steri-Oss(R) for dental implants and Procera(R) for prosthetics.
Further information about Nobel Biocare be found on the World Wide Web at http://www.nobelbiocare.se.
Steri-Oss designs, manufactures and markets dental implants and prosthetic components used in tooth replacement. The company's products have been introduced in more than 35 countries worldwide. Further information about Steri-Oss can be found on the World Wide Web at http://www.steri-oss.com.
The information of this press release is not to be constructed as or constitute a solicitation or an offer to buy or sell any securities. No investment options are provided nor should any be inferred based on this information.
SOURCE Nobel Biocare
-0- 07/02/98 /CONTACT: Carsten Browall, Executive Vice President or Gunilla Ekholtz, Investor Relations Officer of Nobel Biocare Headquarters, 46-31-81-88-36; or Jim Derleth, President or Dorene Lynch, Vice President of Marketing of Nobel Biocare USA, 630-654-9100/
/Web site: http://www.nobelbiocare.se/
/Web site: http:/www.steri-oss.com/
CO: Nobel Biocare; Steri-Oss Inc. ST: Illinois, Sweden IN: MTC SU: TNM
KK-JC -- CGTH029 -- 2731 07/02/98 14:28 EDT http://www.prnewswire.com
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 2, 1998|
|Previous Article:||South African Airways' Latest Boeing 747-400 Flies New Colors|
|Next Article:||Glimcher Defers Common Equity Offering Until Market Conditions Improve|